Revance Asset Turnover vs Total Cash From Operating Activities Analysis
RVNC Stock | USD 3.03 0.79 20.68% |
Revance financial indicator trend analysis is much more than just breaking down Revance prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Revance is a good investment. Please check the relationship between Revance Asset Turnover and its Total Cash From Operating Activities accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.
Asset Turnover vs Total Cash From Operating Activities
Asset Turnover vs Total Cash From Operating Activities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Revance Asset Turnover account and Total Cash From Operating Activities. At this time, the significance of the direction appears to have pay attention.
The correlation between Revance's Asset Turnover and Total Cash From Operating Activities is -0.73. Overlapping area represents the amount of variation of Asset Turnover that can explain the historical movement of Total Cash From Operating Activities in the same time period over historical financial statements of Revance, assuming nothing else is changed. The correlation between historical values of Revance's Asset Turnover and Total Cash From Operating Activities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Asset Turnover of Revance are associated (or correlated) with its Total Cash From Operating Activities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Cash From Operating Activities has no effect on the direction of Asset Turnover i.e., Revance's Asset Turnover and Total Cash From Operating Activities go up and down completely randomly.
Correlation Coefficient | -0.73 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Asset Turnover
The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.Total Cash From Operating Activities
Most indicators from Revance's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Revance current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.At present, Revance's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 124.1 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.16.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 6.3M | 16.5M | 19.4M | 20.3M | Depreciation And Amortization | 19.9M | 33.7M | 13.7M | 8.0M |
Revance fundamental ratios Correlations
Click cells to compare fundamentals
Revance Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Revance fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 340.3M | 720.2M | 531.2M | 581.9M | 478.5M | 331.9M | |
Other Current Liab | 21.6M | 31.6M | 37.8M | 54.4M | 53.8M | 56.5M | |
Total Current Liabilities | 41.0M | 61.0M | 67.3M | 75.7M | 89.2M | 51.0M | |
Total Stockholder Equity | 225.5M | 374.3M | 68.5M | 12.6M | (151.6M) | (144.0M) | |
Other Liab | 47.9M | 77.3M | 75.6M | 80.1M | 92.1M | 96.7M | |
Property Plant And Equipment Net | 41.3M | 47.1M | 69.0M | 67.8M | 90.2M | 94.7M | |
Current Deferred Revenue | 7.9M | 7.9M | 9.4M | 6.9M | 10.7M | 7.6M | |
Net Debt | (141.8M) | (121.4M) | 213.9M | 309.5M | 341.1M | 358.2M | |
Retained Earnings | (844.2M) | (1.1B) | (1.4B) | (1.8B) | (2.1B) | (2.0B) | |
Accounts Payable | 8.0M | 12.7M | 10.6M | 4.5M | 13.8M | 7.0M | |
Cash | 171.2M | 333.6M | 110.6M | 109.0M | 137.3M | 143.1M | |
Non Current Assets Total | 43.7M | 270.2M | 285.0M | 207.2M | 139.6M | 90.0M | |
Non Currrent Assets Other | 1.7M | 4.8M | 13.7M | 35.2M | 32.7M | 34.3M | |
Other Assets | 2.4M | 4.8M | 13.7M | 35.2M | 40.5M | 42.6M | |
Cash And Short Term Investments | 290.1M | 436.5M | 225.1M | 340.7M | 253.9M | 224.4M | |
Common Stock Shares Outstanding | 43.5M | 58.0M | 67.5M | 72.7M | 84.6M | 88.8M | |
Short Term Investments | 119.0M | 102.9M | 114.4M | 231.7M | 116.6M | 81.3M | |
Liabilities And Stockholders Equity | 340.3M | 720.2M | 531.2M | 581.9M | 478.5M | 331.9M | |
Non Current Liabilities Total | 73.8M | 285.0M | 395.4M | 493.6M | 540.8M | 567.9M | |
Other Current Assets | 6.5M | 11.6M | 15.1M | 4.4M | 11.7M | 12.3M | |
Other Stockholder Equity | 1.1B | 1.5B | 1.5B | 1.8B | 1.9B | 2.0B | |
Total Liab | 114.8M | 345.9M | 462.7M | 569.3M | 630.1M | 661.6M | |
Property Plant And Equipment Gross | 41.3M | 47.1M | 69.0M | 67.8M | 90.2M | 94.7M | |
Total Current Assets | 296.6M | 450.0M | 246.1M | 374.7M | 338.9M | 241.9M | |
Accumulated Other Comprehensive Income | (8K) | 3K | (18K) | (374K) | 14K | 14.7K | |
Short Term Debt | 3.5M | 8.9M | 9.5M | 9.8M | 10.9M | 11.8M | |
Property Plant Equipment | 14.8M | 17.5M | 69.0M | 67.8M | 77.9M | 81.8M | |
Common Stock | 52K | 69K | 72K | 82K | 88K | 83.6K | |
Net Tangible Assets | 225.5M | 156.0M | (133.8M) | (91.6M) | (82.4M) | (78.3M) | |
Retained Earnings Total Equity | (684.8M) | (844.2M) | (1.1B) | (1.4B) | (1.3B) | (1.2B) | |
Capital Surpluse | 830.4M | 1.1B | 1.5B | 1.5B | 1.7B | 1.0B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Revance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Revance's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Revance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Revance Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revance. If investors know Revance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revance listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.34) | Revenue Per Share 2.656 | Quarterly Revenue Growth 0.107 | Return On Assets (0.24) | Return On Equity (20.97) |
The market value of Revance is measured differently than its book value, which is the value of Revance that is recorded on the company's balance sheet. Investors also form their own opinion of Revance's value that differs from its market value or its book value, called intrinsic value, which is Revance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revance's market value can be influenced by many factors that don't directly affect Revance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revance's value and its price as these two are different measures arrived at by different means. Investors typically determine if Revance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.